Review Article - Journal of Medical Oncology and Therapeutics (2021) Volume 6, Issue 2
Characteristics of COVID-19 in pediatric patients with malignancy in sulaimani, kurdistan region of iraq
Background: A recent human’s pandemic of respiratory disease caused by a novel (new) coronavirus that rapidly spreads in the community and may causing life threating complications. All those exposed to it is at risk of becoming infected and getting COVID-19. Cancer Patients may be more likely at risk to getting the infection and developing life threating morbidity and even death as those cancer patients may have weakened immunity either because of the cancer treatment or direct effect of the disease.
Objective: To obtain local data on the pattern of children and adolescent with cancer on treatment who have been infected with SARS-CoV-2 in our community and compare it with that of noncancerous patients.
Patients and Methods: A prospective study conducted on 54 pediatric patients with cancer during their treatment with chemotherapy that developed RT-PCR approved COVID-19 in Sulaimani Governorate-Kurdistan region of Iraq from April 2020 to October 2020 were carried out to analyze the demographic features and their clinical manifestation. Data analyzed using SPSS software; version 13 and P-value obtained by Chi-square test.
Results: The median age at diagnosis was about 7 and peak age incidence occurred in adolescent between 13-17 years old with slightly female predominance. There was no correlation between gender and severity; patients with hematological malignancies seem to have more severe COVID-19 manifestation than solid tumor.
Conclusion: Overall morbidity and mortality from COVID-19 in cancer patients is seem to be similar to noncancerous patients.Author(s): Basil kadhim Abdullah Al odda*, Zardasht Bakr Mohammed, Dashti Latif Muhealddina, Khenda Muhammed Abdullah, Ali Omer Qadir, Rebwar Ahmed Shrif, Ghazi Ali Fakrealdeen, Zainab Basil Kadhim Al odda, Ghada Basil Kadhim Al odda